Cargando…

CARD9-Mediated Signaling and Cardiovascular Diseases

Detalles Bibliográficos
Autores principales:	Liu, Xuanyou, Jiang, Bimei, Hao, Hong, Liu, Zhenguo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Translational Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9079849/ https://www.ncbi.nlm.nih.gov/pubmed/35540095 http://dx.doi.org/10.1016/j.jacbts.2022.02.004

Ejemplares similares

CARD9 Signaling, Inflammation, and Diseases
por: Liu, Xuanyou, et al.
Publicado: (2022)

CARD9 deficiency improves the recovery of limb ischemia in mice with ambient fine particulate matter exposure
por: Zhu, Qiang, et al.
Publicado: (2023)

Overcoming Barriers to Development of Novel Therapies for Cardiovascular Disease: Insights From the Oncology Drug Development Experience
por: Khakoo, Aarif Y., et al.
Publicado: (2019)

Needs-Based Innovation in Cardiovascular Medicine: The Stanford Biodesign Process
por: Schwartz, Jonathan G., et al.
Publicado: (2016)

Fallacies of Using the Win Ratio in Cardiovascular Trials: Challenges and Solutions
por: Ajufo, Ezimamaka, et al.
Publicado: (2023)

Advances in Cardiovascular Care: How to Stimulate Innovation While Controlling Cost
por: Weintraub, William S., et al.
Publicado: (2018)

Temporal Trends and Factors Associated With Cardiovascular Drug Development, 1990 to 2012
por: Hwang, Thomas J., et al.
Publicado: (2016)

CARD9 Regulation and its Role in Cardiovascular Diseases
por: Zhang, Haina, et al.
Publicado: (2022)

Probing shear‐stress‐mediated cerebral vasodilatation in humans – it's a NO brainer
por: Fan, Jui‐Lin, et al.
Publicado: (2022)

CARD9 as a potential target in cardiovascular disease
por: Peterson, Matthew R, et al.
Publicado: (2016)

Potentiation of Insulin Signaling Contributes to Heart Failure in Type 2 Diabetes: A Hypothesis Supported by Both Mechanistic Studies and Clinical Trials
por: Packer, Milton
Publicado: (2018)

MicroRNA-Based Diagnostics in Heart Diseases: Current Limitations and Future Perspectives
por: Düsing, Philip, et al.
Publicado: (2021)

An Integrative Human Pan-Cancer Analysis of Cyclin-Dependent Kinase 1 (CDK1)
por: Liu, Xuanyou, et al.
Publicado: (2022)

Should health professionals play the global health security card?
por: Elbe, Stefan
Publicado: (2011)

Research Opportunities in Autonomic Neural Mechanisms of Cardiopulmonary Regulation: A Report From the National Heart, Lung, and Blood Institute and the National Institutes of Health Office of the Director Workshop
por: Mehra, Reena, et al.
Publicado: (2022)

Maintaining Success for Patients With Dilated Cardiomyopathy and Remission of Heart Failure
por: Halliday, Brian P., et al.
Publicado: (2022)

The ups and downs of intermittent hypoxia as a therapy for ventilatory insufficiency
por: O'Halloran, Ken D.
Publicado: (2022)

A shock to the system: neurostimulation therapy for opioid‐induced respiratory depression
por: O'Halloran, Ken D.
Publicado: (2022)

Variations on fetal heart rate variability
por: Shaw, C. J., et al.
Publicado: (2016)

Detection and Management of Geographic Disparities in the TOPCAT Trial: Lessons Learned and Derivative Recommendations
por: Bristow, Michael R., et al.
Publicado: (2016)

Failure to Launch: Targeting Inflammation in Acute Coronary Syndromes
por: Rymer, Jennifer A., et al.
Publicado: (2017)

Molecular Epidemiology of Heart Failure: Translational Challenges and Opportunities
por: Smith, J. Gustav
Publicado: (2017)

Pharmacogenetic Labeling of FDA-Approved Drugs: A Regulatory Retrospective
por: Drozda, Katarzyna, et al.
Publicado: (2018)

Commentary: Renal Nerve Denervation: Is Renervation an Issue?
por: Rothstein, Marcos
Publicado: (2016)

A Perspective on the Delivery of Renal Denervation Therapy Based on Pre-Clinical Data
por: Tellez, Armando, et al.
Publicado: (2016)

Stress‐testing the brain to understand its breaking points
por: Parrish, R. Ryley, et al.
Publicado: (2018)

Like sheep, like humans? Right ventricular remodelling in a preterm‐born ovine model
por: Mohamed, Afifah, et al.
Publicado: (2018)

Chest Compressions During Sustained Inflation During Cardiopulmonary Resuscitation in Newborn Infants Translating Evidence From Animal Studies to the Bedside
por: Schmölzer, Georg M.
Publicado: (2019)

Mendelian Randomization Studies Promise to Shorten the Journey to FDA Approval
por: Roberts, Robert
Publicado: (2018)

Translation of Cardiac Myosin Activation With 2-Deoxy-ATP to Treat Heart Failure Via an Experimental Ribonucleotide Reductase-Based Gene Therapy
por: Thomson, Kassandra S., et al.
Publicado: (2016)

Advancing the Science of Myocardial Recovery With Mechanical Circulatory Support: A Working Group of the National, Heart, Lung, and Blood Institute
por: Drakos, Stavros G., et al.
Publicado: (2017)

Multiorgan Damage in Patients With COVID-19: Is the TGF-β/BMP Pathway the Missing Link?
por: Carlson, F. Roy, et al.
Publicado: (2020)

“Warp Speed” Operations in the COVID-19 Pandemic: Moving Too Quickly?
por: Van Norman, Gail A.
Publicado: (2020)

RNA Vaccines for COVID-19: 5 Things Every Cardiologist Should Know
por: Lin, Chien-Jung, et al.
Publicado: (2020)

Limitations of Animal Studies for Predicting Toxicity in Clinical Trials: Is it Time to Rethink Our Current Approach?
por: Van Norman, Gail A.
Publicado: (2019)

The Heart in COVID-19: Primary Target or Secondary Bystander?
por: Libby, Peter
Publicado: (2020)

Apolipoprotein A-I for Cardiac Recovery Post–Myocardial Infarction
por: Richart, Adele L., et al.
Publicado: (2021)

Von Willebrand Factor Activity in Thrombosis: An Overlooked Target for Intervention?
por: Shalmi, Theodor W., et al.
Publicado: (2021)

Decentralized Clinical Trials: The Future of Medical Product Development?∗
por: Van Norman, Gail A.
Publicado: (2021)

DAPA-CKD: The Beginning of a New Era in Renal Protection
por: Cherney, David Z.I., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7t4uvpuc2uqn4ah65s9so0o0l0